Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 12, 2019

SELL
$20.48 - $27.76 $1.38 Million - $1.87 Million
-67,458 Closed
0 $0
Q1 2019

May 13, 2019

BUY
$19.43 - $26.41 $23,762 - $32,299
1,223 Added 1.85%
67,458 $1.65 Million
Q3 2018

Nov 13, 2018

BUY
$27.65 - $38.39 $389,865 - $541,299
14,100 Added 27.05%
66,235 $2.11 Million
Q2 2018

Aug 09, 2018

BUY
$31.4 - $41.01 $1.64 Million - $2.14 Million
52,135 New
52,135 $1.87 Million

Others Institutions Holding EDIT

About Editas Medicine, Inc.


  • Ticker EDIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,737,200
  • Market Cap $141M
  • Description
  • Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...
More about EDIT
Track This Portfolio

Track Mutual Of America Capital Management LLC Portfolio

Follow Mutual Of America Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mutual Of America Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mutual Of America Capital Management LLC with notifications on news.